RE: Fulvestrant falsely elevates oestradiol levels in immunoassays in postmenopausal women with breast cancer

Eur J Cancer. 2020 Sep:136:204-205. doi: 10.1016/j.ejca.2020.04.050. Epub 2020 Jul 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms* / drug therapy
  • Estradiol / therapeutic use
  • Female
  • Fulvestrant / therapeutic use
  • Humans
  • Immunoassay
  • Postmenopause

Substances

  • Antineoplastic Agents, Hormonal
  • Fulvestrant
  • Estradiol